BGMS, CMND, INDP Lead Pre-Market Movers Friday

Shares of BioGemex (BGMS), Clearmind Medicine (CMND), and Indaptus Therapeutics (INDP) surged in pre-market trading on Friday, June 5, 2026, positioning them among the session’s most active movers. BGMS led the advance, climbing over 15% on volume exceeding 2 million shares, followed by CMND up 12% and INDP gaining 8% as investors reacted to a flurry of corporate updates, including clinical trial progress and strategic partnerships. All three companies released statements before the opening bell, though specific financial terms were not immediately disclosed. The moves set these small-cap biotech stocks on course for a volatile regular trading day, with continued momentum expected if broader markets hold steady.